|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
32,633,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,434,166 |
Avg
Vol: |
650,831 |
52
Week Range: |
$21.74 - $21.74 |
|
Level
I Sector: |
Industrials |
Level
II Sector: |
Diversified Services |
Level
III Sector: |
Research Services |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kuhla Donald E |
Executive Vice President |
|
2005-05-20 |
4 |
S |
$11.70 |
$93,600 |
D/D |
(8,000) |
116,700 |
|
- |
|
Kuhla Donald E |
Executive Vice President |
|
2005-05-20 |
4 |
OE |
$10.00 |
$80,000 |
D/D |
8,000 |
124,700 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2005-05-18 |
4/A |
GD |
$11.85 |
$168,981 |
D/D |
14,260 |
4,847,038 |
|
- |
|
D Ambra Constance M |
10% Owner |
|
2005-05-18 |
4/A |
GD |
$11.85 |
$168,981 |
D/D |
14,260 |
4,847,038 |
|
- |
|
Shultis Kenton L |
VP, OrganichemOfficer |
|
2005-05-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,523 |
|
- |
|
Tartaglia Anthony P |
Director |
|
2005-05-18 |
4 |
B |
$11.85 |
$19,991 |
D/D |
1,687 |
17,445 |
2.39 |
- |
|
Anderson Paul S |
Director |
|
2005-05-18 |
4 |
B |
$11.85 |
$9,990 |
D/D |
843 |
2,736 |
2.39 |
- |
|
Oconnor Kevin |
Director |
|
2005-05-18 |
4 |
B |
$11.85 |
$19,991 |
D/D |
1,687 |
5,620 |
2.39 |
- |
|
D Ambra Constance M |
10% Owner |
|
2005-05-18 |
4 |
GA |
$11.85 |
$168,981 |
D/D |
14,260 |
4,847,038 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2005-05-18 |
4 |
GA |
$11.85 |
$168,981 |
D/D |
14,260 |
4,847,038 |
|
- |
|
Kuhla Donald E |
Executive Vice President |
|
2005-05-18 |
4 |
B |
$11.85 |
$19,991 |
D/D |
1,687 |
116,700 |
2.81 |
- |
|
Kuhla Donald E |
Executive Vice President |
|
2005-04-01 |
4 |
S |
$10.05 |
$150,750 |
D/D |
(15,000) |
115,013 |
|
- |
|
Kuhla Donald E |
Executive Vice President |
|
2005-04-01 |
4 |
OE |
$4.44 |
$124,875 |
D/D |
28,125 |
130,013 |
|
- |
|
D Ambra Constance M |
10% Owner |
|
2005-03-17 |
4 |
B |
$8.99 |
$246,326 |
D/D |
27,400 |
4,861,298 |
2.45 |
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2005-03-17 |
4 |
B |
$8.99 |
$246,326 |
D/D |
27,400 |
4,861,298 |
3.23 |
- |
|
D Ambra Constance M |
10% Owner |
|
2005-03-15 |
4 |
B |
$9.00 |
$409,698 |
D/D |
45,522 |
4,833,898 |
2.45 |
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2005-03-15 |
4 |
B |
$9.00 |
$409,698 |
D/D |
45,522 |
4,833,898 |
3.23 |
- |
|
Frost Mark T |
Chief Financial Officer |
|
2005-03-14 |
4 |
B |
$8.64 |
$43,200 |
D/D |
5,000 |
15,000 |
2.74 |
- |
|
D Ambra Constance M |
10% Owner |
|
2005-03-14 |
4 |
B |
$8.78 |
$189,569 |
D/D |
21,591 |
4,788,376 |
2.45 |
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2005-03-14 |
4 |
B |
$8.78 |
$189,569 |
D/D |
21,591 |
4,788,376 |
3.23 |
- |
|
Grates James J |
VP, Operations |
|
2005-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
27,555 |
|
- |
|
Trova Michael P |
Sr. VP, Medicinal Chemistry |
|
2005-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
62,488 |
|
- |
|
Frost Mark T |
Chief Financial Officer |
|
2005-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
2.66 |
- |
|
D Ambra Constance M |
10% Owner |
|
2005-03-11 |
4 |
B |
$8.43 |
$373,508 |
D/D |
44,307 |
4,766,785 |
2.45 |
- |
|
D Ambra Thomas E Phd |
Chairman, CEO & President |
|
2005-03-11 |
4 |
B |
$8.43 |
$373,508 |
D/D |
44,307 |
4,766,785 |
3.23 |
- |
|
620 Records found
|
|
Page 23 of 25 |
|
|